Literature DB >> 11413376

Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus.

Anita E Matusan1, Peter G Kelley1, Melinda J Pryor1, James C Whisstock1, Andrew D Davidson1, Peter J Wright1.   

Abstract

The N-terminal one-third of the NS3 protein of Dengue virus type 2 (DEN-2) complexes with co-factor NS2B to form an active serine proteinase which cleaves the viral polyprotein. To identify sites within NS3 that may interact with NS2B, seven regions within the NS3 proteinase outside the conserved flavivirus enzyme motifs were mutated by alanine replacement. Five sites contained clusters of charged residues and were hydrophilic. Two sites were hydrophobic and highly conserved among flaviviruses. The effects of five mutations on NS2B/3 processing were examined using a COS cell expression system. Four retained significant proteinase activity. Three of these mutations and two more were introduced into genomic-length cDNA and tested for their effects on virus replication. The five mutant viruses showed reduced plaque size and two of the five showed significantly reduced titres. All seven mutations were mapped on the X-ray crystal structure of the DEN-2 NS3 proteinase: three were located at the N terminus and two at the C terminus of the NS2B-binding cleft. Two mutations were at the C terminus of the proteinase domain and one was solvent-exposed. The study demonstrated that charged-to-alanine mutagenesis in the viral proteinase can be used to produce growth-restricted flaviviruses that may be useful in the production of attenuated vaccine strains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413376     DOI: 10.1099/0022-1317-82-7-1647

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.

Authors:  A E Matusan; M J Pryor; A D Davidson; P J Wright
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

3.  Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.

Authors:  Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 4.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

5.  Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication.

Authors:  René Assenberg; Eloise Mastrangelo; Thomas S Walter; Anil Verma; Mario Milani; Raymond J Owens; David I Stuart; Jonathan M Grimes; Erika J Mancini
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

6.  CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.

Authors:  Haiyan Chu; Sarah L George; Dan T Stinchcomb; Jorge E Osorio; Charalambos D Partidos
Journal:  J Infect Dis       Date:  2015-05-05       Impact factor: 5.226

7.  Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.

Authors:  Jeremy Fuchs; Haiyan Chu; Peter O'Day; Richard Pyles; Nigel Bourne; Subash C Das; Gregg N Milligan; Alan D T Barrett; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2014-09-17       Impact factor: 3.641

8.  Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.

Authors:  Alexander E Aleshin; Sergey A Shiryaev; Alex Y Strongin; Robert C Liddington
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

9.  High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.

Authors:  Anuradha Balasubramanian; Mark Manzano; Tadahisa Teramoto; Rajendra Pilankatta; Radhakrishnan Padmanabhan
Journal:  Antiviral Res       Date:  2016-08-15       Impact factor: 5.970

10.  Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.

Authors:  Ramapraba Appanna; Tan Lian Huat; Lucy Lum Chai See; Phoay Lay Tan; Jamuna Vadivelu; Shamala Devi
Journal:  Clin Vaccine Immunol       Date:  2007-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.